Skip to content
Search AI Powered

Latest Stories

'Stop, study, restart': AstraZeneca expects to get vaccine clarity by year-end

PHARMA giant AstraZeneca should know before the end of the year whether its experimental vaccine protects people against Covid-19, the drugmaker's chief executive Pascal Soriot said on Thursday (10), as long as it can resume trials soon.

The British company suspended late-stage trials this week after an illness in a participant in Britain. The patient was reportedly suffering from symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.


Serum Institute of India has also put trials of AstraZeneca's vaccine candidate on hold until the British drugmaker restarts the trials.

"We are reviewing the situation and pausing India trials," Serum said in a brief statement.

Soriot said during an online event that AstraZeneca did not yet know the diagnosis, adding that it was not clear if the volunteer had transverse myelitis and more tests were needed.

He added that the diagnosis would be submitted to an independent safety committee, and this would usually then tell the company whether trials can be resumed.

"We could still have a vaccine by the end of this year, early next year," Soriot added.

"We will be guided by this committee as to when the trials could restart, so that we can continue our work at the earliest opportunity."

Soriot said the World Health Organization (WHO) had flagged the potential vaccine as the most promising one for coronavirus, and that it was usual for a trial to be suspended.

"It's very common, actually, and many experts will tell you this," Soriot said. "The difference with other vaccine trials is, the whole world is not watching them, of course. They stop, they study, and they restart."

AstraZeneca would supply vaccines to countries at the same time to ensure a fair and equitable distribution, Soriot said, adding that the company was close to having capacity to produce three billion doses at sites set up around the world to prevent governments from restricting distribution.

Shares in AstraZeneca fell on Wednesday after news of the trial's suspension as some observers raised doubts about the timeline for the rollout of a vaccine to help curb the coronavirus pandemic.

Britain's chief scientific adviser, Patrick Vallance, said similar events should be expected but progress on vaccines and therapeutics was positive overall.

"Some will read out this year in terms of efficacy and safety," he told a Downing Street news conference.

"And I think there's a reasonable chance that... we can think about the possibility of vaccination next year sometime at larger levels."

More For You

nhs-hospital-getty

NHS faces pressure as flu admissions rise sharply

FLU cases in the country have surged, with over 5,000 hospital admissions last week, marking a sharp increase as the NHS faces pressure from a winter quad-demic of flu, Covid, respiratory syncytial virus (RSV), and norovirus.

According to The Times, flu admissions rose from 4,102 on Christmas Day to 5,074 by 29 December.

Keep ReadingShow less
AI-diabetes-risk-tool-iStock

World's first AI diabetes risk tool to be tested by NHS in 2025

THE NHS in England is set to launch a world-first trial of an artificial intelligence (AI) tool that predicts the risk of developing type 2 diabetes up to 13 years before symptoms appear.

The trial, scheduled for 2025, will take place at Imperial College Healthcare NHS Trust and Chelsea and Westminster Hospital NHS Foundation Trust, The Guardian reported.

Keep ReadingShow less
Agni: The sacred science of fire and its transformative power

Fire (agni) holds a profound significance in Vedic rituals

iStock

Agni: The sacred science of fire and its transformative power

Ashwini Guruji

Agni, the first word of the Rig Veda, holds a profound significance. It is, in fact, a wondrous element. While most are familiar with fire for its heat and light, very few understand that fire sustains our body and plays a pivotal role in cleansing it and the surrounding elements. Even fewer appreciate its role as a medium to connect with the Devlok (realm of the divine), and hardly anyone explores its potential to manifest changes within and around them. Dhyan Ashram is one such rare place in today’s world where sadhaks (practitioners) experiment with and experience the extraordinary properties of fire.

In Vedic times, yagyas were a routine practice. They were not mere rituals but a precise science designed to invoke and channel the forces of Creation through the medium of fire. The Vedic Shastras detail nearly 400 types of yagyas, each with a specific purpose.

Keep ReadingShow less
genomics-iStock

A recent RHO review highlighted significant gaps in health equity data for genomic services. (Representational image: iStock)

NHS study to tackle inequalities in access to genomic medicine

THE NHS Race and Health Observatory (RHO) and NHS England have launched an 18-month research project to address disparities faced by ethnic minority groups in accessing genomic medicine.

The initiative will examine racial and ethnic biases in the NHS Genomic Medicine Service (GMS) through national and regional assessments of health inequalities.

Keep ReadingShow less

Coffee, a widely consumed beverage, has been associated with reduced risks of several conditions, including heart disease, cognitive decline, and chronic illnesses. (Photo: iStock)
Coffee, a widely consumed beverage, has been associated with reduced risks of several conditions, including heart disease, cognitive decline, and chronic illnesses. (Photo: iStock)

Coffee could extend healthy lifespan by nearly two years, study finds

DRINKING coffee may extend a person’s healthy lifespan by almost two years, according to a study published in the journal Ageing Research Reviews. The research, which reviewed previously published studies, concluded that moderate coffee consumption could correspond to an average increase in healthspan of 1.8 years.

Researchers from Portugal highlighted coffee’s potential in promoting a healthy lifestyle, especially as the global population continues to age. "We know that the world's population is ageing faster than ever, which is why it's increasingly important to explore dietary interventions which may allow people to not only live longer but also healthier lives," said Rodrigo Cunha from the University of Coimbra, who led the study.

Keep ReadingShow less